Informe Final Centro (CRCP) 2000-2009
The FONDAP Center for Cell Regulation and Pathology “Joaquin V. Luco” has as main purposes to stimulate research activity and scientific training in basic areas of modern Biomedical Sciences. The Center is inserted on the grounds of the Facultad de Ciencias Biológicas, in the Central Campus of the P...
| Autor: | |
|---|---|
| Tipo de recurso: | informe técnico |
| Estado: | Versión publicada |
| Fecha de publicación: | 2000 |
| País: | Chile |
| OAI Identifier: | oai:repositorio.anid.cl:10533/237570 |
| Acceso en línea: | https://hdl.handle.net/10533/237570 |
| Access Level: | acceso abierto |
| Palabra clave: | Protección y Promoción de La Salud Proteccion y Promocion de La Salud Ciencias Médicas y de la Salud Biomedicina |
| Sumario: | The FONDAP Center for Cell Regulation and Pathology “Joaquin V. Luco” has as main purposes to stimulate research activity and scientific training in basic areas of modern Biomedical Sciences. The Center is inserted on the grounds of the Facultad de Ciencias Biológicas, in the Central Campus of the Pontificia Universidad Católica de Chile, where the university’s Medical School is also located. Its physical location together with its Project Programs and academic activities promote cooperation and interaction among FONDAP scientists and their peers in other laboratories of our Faculty and medical divisions. The Programs Project of the Center addressed during 2000-2004 two major research areas: 1) The protein traffic mechanisms that determine the composition and dynamics of the cell surface, especially in cells with polarized phenotypes, and; 2) Signaling receptors and transduction systems related with vascular physiology, muscle differentiation and neurotoxicity. These two areas include experimental model systems directly related with pathological conditions such as Alzheimer’s disease, cancer, hypertension, autoimmunity and muscular dystrophy, among others. Several aspects of the basic knowledge produced by the Center have potential applicability in the design of new strategies for therapeutics in some of these diseases. |
|---|